-
Restoring the damaged cells in Parkinson’s disease.
According to a groundbreaking clinical trials program, which targeted an experimental treatment directly to the brain, offers hope that the damaged cells can be restored in Parkinson’s disease. The study examined whether improving the levels of Glial Cell Line Derived Neurotrophic Factor (GDNF), a naturally-occurring growth factor, in patients with Parkinson’s disease can renew dying dopamine brain cells and reverse the condition.
Log in to reply.